Evidence map›Paper›PMID 41292633›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Identifying Distinct Tourette Disorder Subtypes using Clinical Data.

Subramanian Krishnamurthy, Tourette International Collaborative Genetics (TIC Genetics), Robert A King, Jay A Tischfield, Gary A Heiman, Jinchuan Xing

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subramanian KrishnamurthyDepartment of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Tourette International Collaborative Genetics (TIC Genetics)
Robert A KingYale Child Study Center, Yale School of Medicine, New Haven, CT 06510, USA.
Jay A TischfieldDepartment of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Gary A HeimanDepartment of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Jinchuan XingDepartment of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Funding

NIMH Center Repository Supporting Stem Cell ResearchU24MH068457 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M, KNOWLES, JAMES A · 2003 to 2024
$213.8M
1/7 Collaborative Genomic Studies of Tourette Disorder.R01MH115958 · NIMH · RUTGERS, THE STATE UNIV OF N.J. · PI HEIMAN, GARY A., TISCHFIELD, JAY ARNOLD · 2018 to 2023
$6.8M
2/7-Collaborative genomic studies of Tourette DisorderR01MH115963 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STATE, MATTHEW W., WILLSEY, ARTHUR JEREMY · 2018 to 2022
$4.9M
4/7-Collaborative genomic studies of Tourette DisorderR01MH115962 · NIMH · CINCINNATI CHILDRENS HOSP MED CTR · PI GILBERT, DONALD L · 2018 to 2022
$810k
7/7-Collaborative genomic studies of Tourette DisorderR01MH115959 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI COFFEY, BARBARA JANE · 2018 to 2022
$690k
3/7-Collaborative genomic studies of Tourette DisorderR01MH115960 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI ROSEN, ALYSSA · 2018 to 2022
$595k
Collaborative Genomic Studies of Tourette Disorder SupplementR01MH115961 · NIMH · UNIVERSITY OF IOWA · PI KUPERMAN, SAMUEL · 2018 to 2022
$475k
6/7-Collaborative genomic studies of Tourette Disorder.R01MH115993 · NIMH · SEATTLE CHILDREN'S HOSPITAL · PI ZINNER, SAMUEL HAMILTON · 2018 to 2022
$369k
NIMH NIH HHS R01 MH115958NIMH NIH HHS R01 MH115959NIMH NIH HHS R01 MH115960NIMH NIH HHS R01 MH115961NIMH NIH HHS R01 MH115962NIMH NIH HHS R01 MH115963NIMH NIH HHS R01 MH115993NIMH NIH HHS U24 MH068457
6 · The paper itself

Abstract

Background: Tourette Disorder (TD), or Tourette Syndrome, is a highly heterogeneous childhood-onset neurodevelopmental disorder with a global prevalence of 0.5%. TD's large phenotypic heterogeneity, variable heritability patterns, and frequent but varied comorbidity with other neurodevelopmental disorders indicate that different TD patients might have different etiologies. Objectives: In this study, we performed unsupervised clustering of clinical data, such as categorical diagnoses and comorbidities, from 865 subjects with TD from the Tourette International Collaborative Genetics (TIC Genetics) study to detect Tourette Disorder subtypes. Methods: We used two different clustering methods, K-Means and Bayesian Hierarchical Clustering to detect phenotypic subtypes. Results: We identified five distinct, clinically relevant subtypes. These subtypes are characterized by both previously described TD comorbidities, such as Obsessive-Compulsive Disorder (OCD) and Attention Deficit/Hyperactivity Disorder (ADHD), as well as other characteristics, such as sex and region. Conclusions: Defining clinically relevant TD subtypes could enable better diagnostics, treatment, and the understanding of TD etiology. In addition, stratified analysis of genetic data based on these phenotypic subtypes may help identify genes contributing to each TD subtype and provide insights into the disease variability.

Identifiers

PMID41292633
PMCPMC12642721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.